Maio Li Pan
Director/Board Member at MingMed Biotechnology Co., Ltd.
Maio Li Pan active positions
| Companies | Position | Start | End |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Director/Board Member | 24/06/2022 | - |
Career history of Maio Li Pan
Training of Maio Li Pan
| Guangdong University of Technology | Undergraduate Degree |
Statistics
International
| China | 3 |
Operational
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Stock Market
- Insiders
- Maio Li Pan
- Experience
